AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Ocrelizumab'
:
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Publication Year: 2016
DOI: https://doi.org/10.1056/nejmoa1606468
Abstract:
Add to Library
Authors:
Xavier Montalbán
Stephen L. Hauser
Ludwig Kappos
Douglas L. Arnold
Amit Bar‐Or
Giancarlo Comi
de Sèze
Gavin Giovannoni
Hans‐Peter Hartung
Bernhard Hemmer
Fred Lublin
Kottil Rammohan
Krzysztof Selmaj
Anthony Traboulsee
Annette Sauter
Donna Masterman
Paulo Fontoura
Shibeshih Belachew
Hideki Garren
Nicole Mairon
Peter Chin
Jerry S. Wolinsky
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Publication Year: 2016
DOI: https://doi.org/10.1056/nejmoa1601277
Abstract:
Add to Library
Authors:
Stephen L. Hauser
Amit Bar‐Or
Gıancarlo Comı
Gavin Giovannoni
Hans‐Peter Hartung
Bernhard Hemmer
Fred Lublin
Xavier Montalbán
Kottil Rammohan
Krzysztof Selmaj
Anthony Traboulsee
Jerry S. Wolinsky
Douglas L. Arnold
Gaëlle Klingelschmitt
Donna Masterman
Paulo Fontoura
Shibeshih Belachew
Peter Chin
Nicole Mairon
Hideki Garren
Ludwig Kappos
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
Publication Year: 2011
DOI: https://doi.org/10.1016/s0140-6736(11)61649-8
Abstract:
Add to Library
Authors:
Ludwig Kappos
David Li
Peter A. Calabresi
Paul O’Connor
Amit Bar‐Or
Frederik Barkhof
Ming Yin
David Leppert
Robert Glanzman
Jeroen Tinbergen
Stephen L. Hauser
Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III Study
Publication Year: 2013
DOI: https://doi.org/10.1002/art.38037
Abstract:
Add to Library
Authors:
Eduardo Mysler
Alberto Spindler
Renato Guzmán
Marc Bijl
David Jayne
Richard Furie
Frédéric Houssiau
Jörn Drappa
David Close
Romeo Maciuca
Kajal Rao
Saba Shahdad
Paul Brunetta
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis
Publication Year: 2020
DOI: https://doi.org/10.1212/wnl.0000000000010380
Abstract:
Add to Library
Authors:
Amit Bar‐Or
Jonathan Calkwood
Cathy Chognot
Joanna Evershed
Edward Fox
Ann Herman
Marianna Manfrini
John McNamara
Derrick Robertson
Daniela Stokmaier
Jeanette Wendt
Kevin Winthrop
Anthony Traboulsee
Ocrelizumab, a humanized anti‐CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo‐controlled, dose‐ranging study
Publication Year: 2008
DOI: https://doi.org/10.1002/art.23732
Abstract:
Add to Library
Authors:
Mark C. Genovese
Jeffrey Kaine
Mitchell B. Lowenstein
José Del Giudice
Andrew R. Baldassare
Joy Schechtman
Edward J. Fudman
Michael Kohen
Sheila Gujrathi
Robert G. Trapp
Nadera Sweiss
Greg Spaniolo
Wolfgang Dummer
Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program
Publication Year: 2014
DOI: https://doi.org/10.1371/journal.pone.0087379
Abstract:
Add to Library
Authors:
Paul Emery
William F. C. Rigby
Paul P. Tak
Thomas Dörner
Ewa Olech
Carmen Martín
Laurie Millar
Helen Travers
Elena Fisheleva
Ocrelizumab: a new milestone in multiple sclerosis therapy
Publication Year: 2018
DOI: https://doi.org/10.1177/1756286418773025
Abstract:
Add to Library
Authors:
Patricia Mulero
Luciana Midaglia
Xavier Montalbán
The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects
Publication Year: 2015
DOI: https://doi.org/10.1177/1756285615601933
Abstract:
Add to Library
Authors:
Per Soelberg Sørensen
Morten Blinkenberg
Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients
Publication Year: 2018
DOI: https://doi.org/10.3390/cells8010012
Abstract:
Add to Library
Authors:
Stefan Gingele
Thais Langer Jacobus
Franz Felix Konen
Martin W. Hümmert
Kurt‐Wolfram Sühs
Philipp Schwenkenbecher
Jonas Ahlbrecht
Nora Möhn
Lars Hendrik Müschen
Lena Bönig
Sascha Alvermann
Reinhold E. Schmidt
Martin Stangel
Roland Jacobs
Thomas Skripuletz
B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design
Publication Year: 2013
DOI: https://doi.org/10.1186/ar3910
Abstract:
Add to Library
Authors:
Venkat Reddy
David Jayne
David Close
David Isenberg
Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab
Publication Year: 2021
DOI: https://doi.org/10.1001/jamaneurol.2021.3599
Abstract:
Add to Library
Authors:
Livnat Brill
Ariel Rechtman
Omri Zveik
Nitzan Haham
Esther Oiknine‐Djian
Dana G. Wolf
Netta Levin
Catarina Raposo
Adi Vaknin‐Dembinsky
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
Publication Year: 2020
DOI: https://doi.org/10.1016/j.msard.2020.102120
Abstract:
Add to Library
Authors:
Giovanni Novi
Małgorzata Mikulska
Federica Briano
Federica Toscanini
Francesco Tazza
Antonio Uccelli
Matilde Inglese
Ocrelizumab: a step forward in the evolution of B-cell therapy
Publication Year: 2009
DOI: https://doi.org/10.1517/14712590903018837
Abstract:
Add to Library
Authors:
Fariha Kausar
Khader N. Mustafa
Ghaleb Sweis
Ray Sawaqed
Khaldoon Alawneh
Rafah Salloum
Maria Badaracco
Timothy B. Niewold
Nadera Sweiss
Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis
Publication Year: 2017
DOI: https://doi.org/10.1007/s13311-017-0557-4
Abstract:
Add to Library
Authors:
Jeffrey M. Gelfand
Bruce Cree
Stephen L. Hauser
Found 6235 results in 0.058 seconds
What is Boolean Searches
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"